Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel
Clinical trial NCT01578564 · COMPLETED
Trial details
- NCT number
- NCT01578564
- Sponsor
- Soricimed Biopharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2015-07-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.